The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health

Roger J. Bedimo; Henning Drechsler; Mamta Jain; James Cutrell; Song Zhang; Xilong Li; Irfan Farukhi; Rosinda Castanon; Pablo Tebas; Naim M. Maalouf

doi:10.1371/journal.pone.0106221

Loading metrics

Open Access

Peer-reviewed

Research Article

The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health

Roger J. Bedimo ,

* E-mail: roger.bedimo@va.gov

Affiliation Department of Medicine, VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯
Henning Drechsler,

Affiliation Department of Medicine, VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯
Mamta Jain,

Affiliation Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯
James Cutrell,

Affiliation Department of Medicine, VA North Texas Health Care System, Dallas, Texas, United States of America
⨯
Song Zhang,

Affiliation Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯
Xilong Li,

Affiliation Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯
Irfan Farukhi,

Affiliation Department of Nuclear Medicine, VA North Texas Health Care System, Dallas, Texas, United States of America
⨯
Rosinda Castanon,

Affiliation Department of Nuclear Medicine, VA North Texas Health Care System, Dallas, Texas, United States of America
⨯
Pablo Tebas,

Affiliation Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯
Naim M. Maalouf

Affiliation Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America
⨯

The RADAR Study: Week 48 Safety and Efficacy of RAltegravir Combined with Boosted DARunavir Compared to Tenofovir/Emtricitabine Combined with Boosted Darunavir in Antiretroviral-Naive Patients. Impact on Bone Health

Roger J. Bedimo,
Henning Drechsler,
Mamta Jain,
James Cutrell,
Song Zhang,
Xilong Li,
Irfan Farukhi,
Rosinda Castanon,
Pablo Tebas,
Naim M. Maalouf

Published: August 29, 2014
https://doi.org/10.1371/journal.pone.0106221

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Radar
Is the Subject Area "Radar" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
Bone density
Is the Subject Area "Bone density" applicable to this article?

Thanks for your feedback.
Antiretrovirals
Is the Subject Area "Antiretrovirals" applicable to this article?

Thanks for your feedback.
Highly-active antiretroviral therapy
Is the Subject Area "Highly-active antiretroviral therapy" applicable to this article?

Thanks for your feedback.
RNA analysis
Is the Subject Area "RNA analysis" applicable to this article?

Thanks for your feedback.
Chi square tests
Is the Subject Area "Chi square tests" applicable to this article?

Thanks for your feedback.